Aurobindo Pharma Ltd AUROPHARMA
NSE · India · Health Technology
INR 1,676.80+4.80 (+0.29%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 2026-08-05 | 17.86 | 17.26 | +3.5% | INR 91.50B | +1.6% | +0.2%INR 1,585.90→INR 1,588.90 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.